Triple-Positive Metastatic Breast Cancer

Panelists Adam M. Brufsky, MD, PhD; Kimberly L. Blackwell, MD; Debu Tripathy, MD; José Baselga, MD, PhD; Denise A. Yardley, MD; and Carlos L. Arteaga, MD, discuss using chemotherapy and HER2 monoclonal antibodies to treat triple-positive metastatic breast cancer and their personal approaches.

• Kategorija